C07K 14/57536
Endothelin, vasoactive intestinal contractor [vic]
Official title: {Endothelin, vasoactive intestinal contractor [VIC]}
C07K14/57536 (Endothelin, vasoactive intestinal contractor [vic]) appears on 80 US grants and 44 published applications in this corpus.
Search patents in C07K- Granted patents
- 80
- Published applications
- 44
- Assignees
- 40
- Inventors
- 159
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 6 | 0 |
| 1997 | 7 | 0 |
| 1998 | 8 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 1 |
| 2003 | 1 | 3 |
| 2004 | 5 | 1 |
| 2005 | 0 | 2 |
| 2006 | 2 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 3 | 2 |
| 2010 | 1 | 2 |
| 2011 | 2 | 4 |
| 2012 | 1 | 3 |
| 2013 | 1 | 4 |
| 2014 | 5 | 2 |
| 2015 | 1 | 0 |
| 2016 | 1 | 4 |
| 2017 | 0 | 1 |
| 2018 | 2 | 0 |
| 2019 | 0 | 2 |
| 2020 | 2 | 2 |
| 2021 | 3 | 5 |
| 2022 | 1 | 2 |
| 2023 | 0 | 0 |
| 2024 | 3 | 0 |
| 2025 | 1 | 0 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neutralizing antibodies to human endothelin17 Mar 2026US 12,577,300 B2Father Flanagan's Boys' Home Business
- Composition for promoting efficiency of somatic cell replication4 Nov 2025US 12,460,177 B2Seoul National University Hospital
- Methods of treatment with anti-PACAP antibodies10 Dec 2024US 12,162,936 B2H. Lundbeck A.S.
- Anti-PACAP antibodies and uses thereof3 Sep 2024US 12,077,581 B2H. Lundbeck A.S.
- Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion28 May 2024US 11,993,648 B2H. Lundbeck A.S.
- Neutralizing antibodies to human endothelin23 Apr 2026US 2026/0109760 A1Father Flanagan's Boys' Home doing business as Boys Town National Research Hospital
- Method for producing nonhuman primate animal model of cerebral infarction and pharmaceutical composition for treatment of cerebral infarction5 Mar 2026US 2026/0060221 A1Astellas Pharma Inc.
- Anti-pacap antibodies and uses thereof15 Sep 2022US 2022/0289836 A1H. Lundbeck A.S.
- Neutralizing antibodies to human endothelin23 Jun 2022US 2022/0195034 A1Father Flanagan's Boys' Home doing business as Boys Town National Research Hospital
- Methods of determining whether anti-pacap antibodies inhibit pacap-associated photophobia or light aversion9 Dec 2021US 2021/0380676 A1H. Lundbeck A.S.
Most cited
By later US patents
- DNA coding for a human vasoconstrictive peptide and use thereof76US 5,756,344 ATakeda Chemical Industries, Ltd. · 1998
- Endothelin antagonistic cyclic pentapeptides61US 5,114,918 ABanyu Pharmaceutical Co., Ltd. · 1992
- Endotherlin antagonists55US 5,382,569 AWarner-Lambert Company · 1995
- Endothelin analogs and uses thereof34US 5,352,659 ATakeda Chemical Industries, Ltd. · 1994
- Endothelin Antagonists II33US 5,550,110 AWarner-Lambert Company · 1996